Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gotlib

Showing results (61-70 of 247) with videos related to

Pageof 25
Sort By:
Blood Reviews|April 27, 2020
Non-hematologic diagnosis of systemic mastocytosis: Collaboration of radiology and pathologyKerem Ozturk, Zuzan Cayci, Jason Gotlib, et al.
American Journal of Hematology|November 14, 2008
A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromesJason Gotlib, Philip Lavori, Sylvia Quesada, et al.
Expert Opinion on Biological Therapy|October 16, 2020
Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurinJason Gotlib, Hanneke C Kluin-Nelemans, Cem Akin, et al.
Expert Review of Hematology|October 3, 2013
Practical management of patients with myelofibrosis receiving ruxolitinibClaire Harrison, Ruben Mesa, David Ross, et al.
American Journal of Hematology|November 15, 2011
Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case reviewCelalettin Ustun, Natasha M Savage, Jason Gotlib, et al.
The Journal of Molecular Diagnostics : JMD|July 11, 2006
Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysisMarla Lay, Rajan Mariappan, Jason Gotlib, et al.
Blood|April 9, 2004
The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and managementJason Gotlib, Jan Cools, James M Malone, et al.
The Journal of Molecular Diagnostics : JMD|December 5, 2009
Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratoryJason D Merker, Carol D Jones, Stephen T Oh, et al.
Hemasphere|November 16, 2020
Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase <i>FIP1L1-PDGFRA</i>-Associated Myeloid Neoplasm With EosinophiliaJuhi Jain, Elizabeth P Weinzierl, Debra Saxe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosisVikas Gupta, Jason Gotlib, Jerald P Radich, et al.
Pageof 25

Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Blood Reviews|April 27, 2020
Non-hematologic diagnosis of systemic mastocytosis: Collaboration of radiology and pathologyKerem Ozturk, Zuzan Cayci, Jason Gotlib, et al.
American Journal of Hematology|November 14, 2008
A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromesJason Gotlib, Philip Lavori, Sylvia Quesada, et al.
Expert Opinion on Biological Therapy|October 16, 2020
Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurinJason Gotlib, Hanneke C Kluin-Nelemans, Cem Akin, et al.
Expert Review of Hematology|October 3, 2013
Practical management of patients with myelofibrosis receiving ruxolitinibClaire Harrison, Ruben Mesa, David Ross, et al.
American Journal of Hematology|November 15, 2011
Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case reviewCelalettin Ustun, Natasha M Savage, Jason Gotlib, et al.
The Journal of Molecular Diagnostics : JMD|July 11, 2006
Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysisMarla Lay, Rajan Mariappan, Jason Gotlib, et al.
Blood|April 9, 2004
The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and managementJason Gotlib, Jan Cools, James M Malone, et al.
The Journal of Molecular Diagnostics : JMD|December 5, 2009
Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratoryJason D Merker, Carol D Jones, Stephen T Oh, et al.
Hemasphere|November 16, 2020
Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase <i>FIP1L1-PDGFRA</i>-Associated Myeloid Neoplasm With EosinophiliaJuhi Jain, Elizabeth P Weinzierl, Debra Saxe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosisVikas Gupta, Jason Gotlib, Jerald P Radich, et al.
Pageof 25